Westlake Chemical Partners LP reported third-quarter EPS of $0.46, exceeding analyst estimates by $0.16. Revenue of $314.45 million missed consensus, though stock performance remained positive over th
Westlake Chemical Partners will report Q3 2026 earnings on October 29th, with analysts forecasting $0.2996 EPS and $336.33 million revenue. The company maintains a Moderate Buy rating following a rece
Westlake Chemical Partners LP stock analysis highlights weak near-term sentiment despite long-term strength, providing AI-generated trading strategies with specific entry and risk management levels.
Westlake Chemical Partners stock traded below its 200-day moving average at $21.5150, maintaining a Moderate Buy consensus among analysts. The company also announced a quarterly dividend of $0.4714 pe
Westlake Chemical Partners projects 6.9% annual revenue growth and 9.7% EPS growth, while analysts lowered the price target to $26.00 citing dividend sustainability concerns.
Westlake Chemical Partners reported Q2 2026 net income of $14 million, supported by its fixed-margin Ethylene Sales Agreement. Management discussed extending credit agreements and announced a finance
Westlake Chemical Partners extended credit facilities to July 2031 and maintained its quarterly distribution at $0.4714 per unit following Q2 2026 net income of $14.2 million.
Westlake Chemical Partners reported quarterly earnings of $0.40 per share, missing estimates by $0.01, with revenue falling short at $297.1 million against a $537 million forecast.
Westlake Chemical Partners reported Q2 2026 earnings of $0.40 per unit on $297.1 million revenue, missing analyst estimates but increasing distributable cash flow by 20%. Stable financial metrics were
Stock Traders Daily releases a precision trading analysis for Westlake Chemical Partners LP (WLKP), outlining neutral sentiment, risk zones, and institutional strategies.
Financial data for Westlake Chemical Partners LP indicates that the Enterprise Value to EBITDA forward metric is currently unavailable, showing no trades or period value change.
Westlake Chemical Partners (WLKP) exhibits neutral near-term trends with a potential long-term positive bias. The analysis highlights a 28.2:1 risk-reward setup targeting a 7.6% gain via AI-generated
Westlake Chemical Partners LP stock performance and financial metrics are detailed, covering market cap, dividends, and historical price ranges. Analyst estimates provide forecasts for upcoming earnin
Westlake Chemical Partners LP reports robust financial health with a score of 9.76, driven by a 28.64% YoY revenue increase and a 186.36% surge in net profit. The analysis highlights strong profitabil
Westlake Chemical Partners LP holds a valuation score of 8.37, ranking 32 out of 68 in the chemicals sector. The company's P/E ratio stands at 14.19, positioned 19.60% below its recent high.
Jonathan Baksht, SVP and CFO of Westlake Chemical Partners LP, filed an initial Form 3 insider ownership report. The document shows no reported transactions or share holdings at the time of filing.
Simply Wall St analyzes Westlake Chemical Partners' financial health, noting trading below fair value despite high debt and dividend concerns linked to Q1 2026 earnings.
Westlake Chemical Partners reported significantly improved Q1 2026 results with net income nearly doubling to $81.7 million, driven by higher ethylene production. The partnership also declared a quart
Westlake Chemical Partners reported Q1 2026 net income of $14.2 million, up from $4.9 million year-ago, driven by higher production volumes after Petro 1 turnaround. The company also declared a quarte
AI-driven analysis identifies neutral near-term readings and elevated downside risk for Westlake Chemical Partners (WLKP), noting mid-term sentiment may be stalling.
ChemBrief